Effects of transcutaneous electrical nerve stimulation in complex regional pain syndrome: a systematic review.
Featured on Physle Daily · Friday, 17 July 2026
Complex regional pain syndrome is a disabling chronic pain condition that can develop after injury or surgery, often causing severe pain, swelling, and loss of function in the affected limb. Transcutaneous electrical nerve stimulation, or TENS, is a noninvasive treatment that delivers mild electrical impulses through the skin in an attempt to reduce pain. Researchers systematically searched five major medical databases for rigorous studies examining whether TENS actually helps people with CRPS.
They found only two clinical trials involving a combined 38 participants that met their criteria. One trial suggested TENS may reduce pain and improve movement and swelling compared to a sham placebo treatment, but the other was a small feasibility study that did not reach its target sample size and could not make direct comparisons between groups. The authors concluded there is currently insufficient evidence to determine whether TENS is truly effective for this condition, and that larger, better-designed studies are needed before clinicians and patients can rely on clear answers.
If you live with complex regional pain syndrome, you know how limiting the pain and swelling can be. TENS is a device that sends gentle electrical pulses through electrode pads on your skin to try to ease pain without medication or invasive procedures.
Researchers looked at all the published studies testing whether TENS actually works for CRPS, and they found very few high-quality trials to examine. One study did suggest that TENS may help reduce pain and improve how the affected limb moves and swells compared to a fake treatment, which is a positive signal.
However, with only two very small studies available, and one of them not even being a complete comparison, the evidence is too thin right now to say for certain whether TENS will help you. This does not mean TENS is ineffective, just that we simply do not yet have enough reliable research to know for sure.
This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.
The evidence base for TENS in CRPS remains sparse. A systematic search across five major databases up to mid-2025 identified only two RCTs meeting inclusion criteria, totaling just 38 participants, which highlights how little rigorous research has been conducted in this area.
One trial reported improvements in pain intensity, mobility, and edema with conventional TENS versus sham control, offering some signal of potential benefit. The second study was a feasibility trial that fell short of its recruitment target and reported only individual-level data without between-group statistical comparisons, limiting its interpretive value.
Both studies carried some concern regarding reporting clarity in data analysis, and one lacked protocol registration, introducing additional uncertainty about their methodological rigor. The authors rightly conclude that current evidence is insufficient to inform clinical decision-making, and that properly powered, well-designed RCTs with transparent protocols and adequate participant numbers are needed before TENS can be confidently positioned in CRPS management.
Only two clinical trials met inclusion criteria from 517 records screened, involving 38 total participants, the majority of whom were women.
One study reported improvements in pain, mobility, and edema with conventional TENS compared to sham TENS; the other was a feasibility study without between-group comparisons.
The authors determined there is insufficient evidence to judge the efficacy of TENS for pain relief and functional improvement in CRPS, and further studies are needed.
Source
Pain management
Righi NC, Liebano RE, Johnson MI et al. · 2025
doi: 10.1080/17581869.2025.2529150